EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Health Care Investment Banking Group
Ernst & Young Capital Advisors, LLC’s (EYCA) Health Care group is an industry-focused investment banking team with transaction experience across a broad range of health care subsectors.
The team
Slava Girzhel
US Head of Health Care Investment Banking and Senior Managing Director, Ernst & Young Capital Advisors, LLC
Karan Jolly
Managing Director, US Health Care Investment Banking, Ernst & Young Capital Advisors, LLC
Jeff McMahon
Ernst & Young Capital Advisors, LLC US Health Care Investment Banking, Managing Director
What we can do for you
Health care in the US is undergoing a fundamental transformation — the move to “Health 2.0,” the consumer-centric, outcomes-driven, prevention-focused future of health care. This tectonic shift is driving significant consolidation and convergence as providers and payers across the health care ecosystem look to improve quality, reduce costs, and improve population health.
Our EYCA Health Care practice has a proud tradition and strong track record of successfully advising health care organizations and investors as they navigate the increasingly challenging health care landscape. We advise clients on their strategic and transaction alternatives.
Our health care investment banking team provides clients with a broad range strategy and transactions, including mergers & acquisitions advisory; strategic business review & development; corporate finance analyses; corporate divestiture advisory; and debt & equity capital raising advisory.
Our professionals have deep sector knowledge built over years of focused industry coverage and our team focuses exclusively on its health care services clients. We work collaboratively with a wide range of organizations, including private for-profit companies; publicly traded companies; and not-for-profit entities.
Our team focuses our industry coverage across seven primary sectors: Health Care Services; Managed Care; Health Care IT; Pharma Services/Distribution; Therapeutics; Tools & Diagnostics; and Medical Technology.
Within those primary sectors, our team has experience advising clients across a diverse range of health care subverticals, including:
Health Care Services
- Acute care
- Alternate site services
- Ambulatory surgery centers
- Behavioral health
- Clinical/hospital outsourcing
- Dental Services
- Diagnostic services
- Dialysis
- Home health and hospice
- Long-term care
- Physician services
- Rehabilitation/physical therapy
- Urgent care
Managed Care
- ACO solutions
- Care/disease management
- Consumer-directed health care
- Managed care organizations
- Pharmacy benefit managers
- Population health
- Specialty benefit managers
- Workers’ compensation
Health Care IT
- Ambulatory solutions
- Clinical management
- Data/predictive analytics
- Enterprise solutions
- Mobile health
- Payor solutions
- Population health
- Revenue cycle management
- Telemedicine
Pharma Services/Distribution
- Alternate site distribution
- Compounding pharmacy
- CROs/IRBs
- Drug distribution
- Institutional pharmacy
- Medical-surgical distribution
- Retail pharmacy
- Specialty pharmacy
Therapeutics
- Biosimilars
- Biotechnology
- Branded pharmaceuticals
- Contract manufacturing organizations
- Generic pharmaceuticals
- Specialty pharmaceuticals
Tools & Diagnostics
- Genetic sequencing
- Laboratories
Medical Technology
- Cardiovascular
- CNS
- Diabetes
- Ophthalmology
- Orthopedics
Representative transactions
Explore our services Investment Banking
Our team
Our latest thinking
How CEOs juggle transformation priorities – the art of taking back control
EY CEO survey highlights how CEOs consider AI transformation, ESG and M&A to navigate between immediate profits and future sustainability aspirations. Read more.
The new corporate strategy playing field
Corporate strategy is being upended by new stakeholders, competitors and the need to quickly add differentiating capabilities.
Check the background of this firm or its investment professionals at FINRA’s BrokerCheck.
Ernst & Young Capital Advisors, LLC (EYCA) is a registered broker-dealer and member of FINRA providing sector-specific advice on M&A, debt capital markets, equity capital markets and capital restructuring transactions. It is an affiliate of Ernst & Young LLP serving clients in the US.
